Related Experiment Video
Updated: May 20, 2026

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
Published on: July 17, 2016
Enhancement of myeloma development mediated though myeloma cell-Th2 cell interactions after microbial antigen
Abstract:
Microbial agents are regarded as a potential cause of tumors, but their direct effects on tumors, such as myeloma, are not well studied. Our studies demonstrated that expression of HLA-DR and CD40 on the myeloma cell membrane surface is upregulated by interferon-γ and/or microbial antigens (Ags). Unlike prior studies, our study showed that Th2 cells cannot promote myeloma growth directly. However, Bacillus Calmette-Guerin Vaccine (BCGV)-specific Th2 cells stimulated by BCGV-loaded dendritic cells (DCs) promoted myeloma clonogenicity directly when the myeloma cells expressed major histocompatibility complex Class-II molecules (MHC-II) and took up BCGV Ag. B-cell lymphoma 6 (Bcl-6) protein expression and the proportion of HLA-DR(+) or CD40(+) cells were higher in colonies of Th2 cell-stimulated myeloma cells. Furthermore, anti-HLA-DR or neutralizing CD40 antibody could prevent this increase in Bcl-6 expression and colony number. These results indicate that microbes and microbial Ag-specific Th2 cells may directly impact the biology of myeloma and contribute to tumor progression. Activation may be limited to MHC-II(+) myeloma cells that retain B cell and stem cell characteristics. Taken together, our data suggest that factors involved in microbial Ag presentation, such as DCs, Th2 cells and so on, are potential targets for myeloma therapeutic intervention.
Insights
Microbes and microbial antigens can directly impact myeloma progression. Bacillus Calmette-Guerin Vaccine-specific Th2 cells promote myeloma growth by upregulating HLA-DR and CD40, suggesting new therapeutic targets.
Area of Science:
- Immunology
- Oncology
- Microbiology
Background:
- Microbial agents are potential carcinogens, but their direct role in myeloma tumor biology is unclear.
- Previous research has not established a direct link between Th2 cells and myeloma growth promotion.
Purpose of the Study:
- To investigate the direct effects of microbial antigens and microbial-specific T helper 2 (Th2) cells on myeloma cells.
- To explore the mechanisms by which microbial factors influence myeloma progression and identify potential therapeutic targets.
Main Methods:
- Upregulation of HLA-DR and CD40 on myeloma cells by interferon-γ and microbial antigens.
- Stimulation of Bacillus Calmette-Guerin Vaccine (BCGV)-specific Th2 cells using BCGV-loaded dendritic cells (DCs).
- Assessment of myeloma clonogenicity, B-cell lymphoma 6 (Bcl-6) protein expression, and cell surface marker proportions in Th2 cell-stimulated myeloma cells.
Main Results:
- BCGV-specific Th2 cells directly promoted myeloma clonogenicity in MHC-II(+) myeloma cells that took up BCGV antigen.
- Th2 cell stimulation led to increased Bcl-6 protein expression and a higher proportion of HLA-DR(+) or CD40(+) myeloma cells.
- Blocking HLA-DR or CD40 with antibodies inhibited the increase in Bcl-6 expression and colony number.
Conclusions:
- Microbes and microbial antigen-specific Th2 cells can directly influence myeloma biology and promote tumor progression.
- Activation appears specific to MHC-II(+) myeloma cells with B cell and stem cell characteristics.
- Dendritic cells and Th2 cells involved in microbial antigen presentation are potential targets for myeloma therapy.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
The Tumor Microenvironment
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cell-mediated Immune Responses
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

